Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Neurology
Published in: Current Treatment Options in Neurology 11/2016

01-11-2016 | Movement Disorders (A Videnovich, Section Editor)

Surgical Treatment of Parkinson’s Disease

Authors: Leo Verhagen Metman, MD, PhD, Gian Pal, MD, Konstantin Slavin, MD

Published in: Current Treatment Options in Neurology | Issue 11/2016

Login to get access

Opinion statement

Deep brain stimulation is now an established therapy for Parkinson’s disease, and DBS continues to be refined. Well-established targets, such as the STN and GPi, have shown clear benefit in reducing motor complications in PD, and other more novel targets, such as PPN are being explored. Furthermore, there have been advances in imaging which allow for improved lead placement and also can reduce patient discomfort. The way electrical current is delivered through the DBS lead is also undergoing a transformation, allowing for more options regarding current shaping, steering, and new stimulation paradigms. The future holds promise for novel methodologies of neuromodulation including closed-loop devices and more focused lesion therapies that alter CNS circuitry.
Literature
1.
Horsley V. The Linacre lecture on the function of the so-called motor area of the brain: delivered to the master and fellows of St. John’s College, Cambridge, May 6th, 1909. Br Med J. 1909;2(2533):121–32.CrossRefPubMedPubMedCentral
2.
Spiegel EA, Wycis HT, Marks M, Lee AJ. Stereotaxic apparatus for operations on the human brain. Science. 1947;106(2754):349–50.CrossRefPubMed
3.
Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1–6):344–6.PubMed
4.
Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339(16):1105–11.CrossRefPubMed
5.
Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all Parkinsonian symptoms. Neurosurgery. 1994;35(6):1126,9. discussion 1129–30.
6.
Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2005;64:2008–20.CrossRefPubMed
7.
Melamed E, Ziv I, Djaldetti R. Management of motor control complications in advanced Parkinson’s disease. Mov Disord. 2007;22(Suppl17):S379–84.CrossRefPubMed
8.
The Deep-Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001;345:956–63.CrossRef
9.
Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62(4):554–60.CrossRefPubMed
10.
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2006;355(9):896–908.CrossRefPubMed
11.
Schupbach WM, Maltete D, Houeto JL, du Montcel ST, Mallet L, Welter ML, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68(4):267–71.CrossRefPubMed
12.
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks Jr WJ, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63–73.CrossRefPubMedPubMedCentral
13.
Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65(5):586–95.CrossRefPubMedPubMedCentral
14.
Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov Disord. 2010;25(5):578–86.CrossRefPubMed
15.
Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581–91.CrossRefPubMedPubMedCentral
16.
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362(22):2077–91.CrossRefPubMed
17.
Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11(2):140–9.CrossRefPubMed
18.
Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012;79(1):55–65.CrossRefPubMedPubMedCentral
19.•
Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013;12(1):37–44. This randomized controlled trial demonstrated that there was no significant difference between STN and GPi DBS in functional health after 1 year of surgery.CrossRefPubMed
20.•
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):610–22. This 2-year trial demonstrated that STN stimulation was superior to best medical therapy in PD patients with early motor complications.CrossRefPubMed
21.
Liu Y, Li W, Tan C, Liu X, Wang X, Gui Y, et al. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg. 2014;121(3):709–18.CrossRefPubMed
22.•
Odekerken VJ, Boel JA, Schmand BA, de Haan RJ, Figee M, van den Munckhof P, et al. GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up. Neurology. 2016;86(8):755–61. This study demonstrated that subthalamic nucleus DBS provided more improvement in OFF motor symptoms compared with GPi DBS but with similar risks of cognitive, mood, and behavioral complications.CrossRefPubMed
23.
Morita H, Hass CJ, Moro E, Sudhyadhom A, Kumar R, Okun MS. Pedunculopontine nucleus stimulation: where are we now and what needs to be done to move the field forward? Front Neurol. 2014;5:243.CrossRefPubMedPubMedCentral
24.
Mazzone P, Paoloni M, Mangone M, Santilli V, Insola A, Fini M, et al. Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson’s disease: effects on gait initiation and performance. Gait Posture. 2014;40:357–62.CrossRefPubMed
25.
Mazzone P, Sposato S, Insola A, Scarnati E. The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation. Neurosurgery. 2013;73:894–906.CrossRefPubMed
26.
Mestre TA, Espay AJ, Marras C, Eckman MH, Pollak P, Lang AE. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson’s disease-the EARLYSTIM trial: early is not always better. Mov Disord. 2014;29(14):1751–6.CrossRefPubMed
27.
28.
Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS. Subthalamic nucleus deep brain stimulator placement using highfield interventional magnetic resonance imaging and a skullmounted aiming device: technique and application accuracy. J Neurosurg. 2010;112:479–90.CrossRefPubMedPubMedCentral
29.
Chabardes S, Isnard S, Castrioto A, Oddoux M, Fraix V, Carlucci L, et al. Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up. Acta Neurochir (Wien). 2015;157:729–37.CrossRef
30.
Sillay KA, Rusy D, Buyan-Dent L, Ninman NL, Vigen KK. Widebore 1.5 T MRI-guided deep brain stimulation surgery: initial experience and technique comparison. Clin Neurol Neurosurg. 2014;127:79–85.CrossRefPubMed
31.
Aviles-Olmos I, Kefalopoulou Z, Tripoliti E, et al. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry. 2014;85:1419–25.CrossRefPubMedPubMedCentral
32.
Ostrem JL, Galifianakis NB, Markun LC, et al. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg. 2013;115:708–12.CrossRefPubMed
33.•
Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, et al. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease. J Neurosurg. 2015;23:1–9. This study demonstrated that MRI-guided DBS provided highly accurate lead placement and outcomes comparable to traditional frame-based approaches.
34.
Mirzadeh Z, Chapple K, Lambert M, Dhall R, Ponce FA. Validation of CT-MRI fusion for intraoperative assessment of stereotactic accuracy in DBS surgery. Mov Disord. 2014;29:1788–95.CrossRefPubMed
35.
Burchiel KJ, McCartney S, Lee A, et al. Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg. 2013;119:301–6.CrossRefPubMed
36.
Bot M, van den Munckhof P, Bakay R, Sierens D, Stebbins G, Verhagen ML. Analysis of stereotactic accuracy in patients undergoing deep brain stimulation using nexframe and the Leksell frame. Stereotact Funct Neurosurg. 2015;93(5):316–25.CrossRefPubMed
37.
Cheng CY, Hsing MT, Chen YH, et al. Deep brain stimulation for Parkinson’s disease using frameless technology. Br J Neurosurg. 2014;28:383–6.CrossRefPubMed
38.
Sharma M, Rhiew R, Deogaonkar M, et al. Accuracy and precision of targeting using frameless stereotactic system in deep brain stimulator implantation surgery. Neurol India. 2014;62:503–9.CrossRefPubMed
39.
Miocinovic S, Khemani P, Whiddon R, Zeilman P, Martinez-Ramirez D, Okun MS, et al. Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings. Parkinsonism Relat Disord. 2014;20:1434–7.CrossRefPubMed
40.
Wojtecki L, Vesper J, Schnitzler A. Interleaving programming of subthalamic deep brain stimulation to reduce side effects with good motor outcome in a patient with Parkinson’s disease. Parkinsons Relat Disord. 2011;17:293–4.CrossRef
41.
Baumann CR, Imbach LL, Baumann-Vogel H, et al. Interleaving deep bain stimulation for a patient with both Parkinson’s disease and essential tremor. Mov Disord. 2012;27:1700–1.CrossRefPubMed
42.
Kovacs N, Janszky J, Nagy F, Bal_as I. Changing to interleaving stimulation might improve dystonia in cases not responding to pallidal stimulation. Mov Disord. 2012;27:163–5.CrossRefPubMed
43.
Barbe MT, Dembek TA, Becker J, et al. Individualized current shaping reduces DBS-induced dysarthria in patients with essential tremor. Neurology. 2014;82:614–9.CrossRefPubMedPubMedCentral
44.
Pollo C, Kaelin-Lang A, Oertel MF, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain. 2014;137:2015–26.CrossRefPubMed
45.•
Contarino MF, Bour LJ, Verhagen R, Lourens MA, de Bie RM, van den Munckhof P, et al. Directional steering: a novel approach to deep brain stimulation. Neurology. 2014;83:1163–9. This study demonstrated that steering of DBS current is well tolerated, can increase the threshold for side effects, and lead to an improvement in the therapeutic window of STN DBS compared with traditional spherical stimulation.CrossRefPubMed
46.
Xie T, Vigil J, MacCracken E, et al. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015;84:415–20.CrossRefPubMedPubMedCentral
47.
Vallabhajosula S, Haq IU, Hwynn N, Oyama G, Okun M, Tillman MD, et al. Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson’s disease: a quantitative study. Brain Stimul. 2015;8:64–75.CrossRefPubMed
48.
Reich MM, Steigerwald F, Sawalhe AD, et al. Short pulse width widens the therapeutic window of subthalamic neurostimulation. Ann Clin Transl Neurol. 2015;2:427–32.CrossRefPubMedPubMedCentral
49.
Brocker DT, Swan BD, Turner DA, et al. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson’s disease. Exp Neurol. 2013;239:60–7.CrossRefPubMed
50.
Priori A, Foffani G, Rossi L, Marceglia S. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations. Exp Neurol. 2013;245:77–86.CrossRefPubMed
51.
52.
Kuhn AA, Tsui A, Aziz T, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson’s disease relates to both bradykinesia and rigidity. Exp Neurol. 2009;215:380–7.CrossRefPubMed
53.
Beudel M, Little S, Pogosyan A, et al. Tremor reduction by deep brain stimulation is associated with gamma power suppression in Parkinson’s disease. Neuromodulation. 2015;18:349–54.CrossRefPubMedPubMedCentral
54.
55.
Basu I, Graupe D, Tuninetti D, Shukla P, Slavin KV, Verhagen Metman L, et al. Pathological tremor prediction using surface electromyogram and acceleration: potential use in ‘ON-OFF’ demand driven deep brain stimulator design. J Neural Eng. 2013;10:036019.CrossRefPubMedPubMedCentral
56.
Graupe D, Tuninetti D, Slavin KV, Basu I. Closed-loop electrochemical feedback system for DBS. J Neurosurg. 2014;121:762–3.CrossRefPubMed
57.
Chang SY, Kimble CJ, Kim I, et al. Development of the Mayo Investigational Neuromodulation Control System: toward a closed-loop electrochemical feedback system for deep brain stimulation. J Neurosurg. 2013;119:1556–65.CrossRefPubMedPubMedCentral
58.
Grahn PJ, Mallory GW, Khurram OU, et al. A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies. Front Neurosci. 2014;8:169.PubMedPubMedCentral
59.
Okun MS, Stover NP, Subramanian T, Gearing M, Wainer BH, Holder CA, et al. Complications of gamma knife surgery for Parkinson disease. Arch Neurol. 2001;58(12):1995–2002.CrossRefPubMed
60.
Dobrakowski PP, Machowska-Majchrzak AK, Labuz-Roszak B, Majchrzak KG, Kluczewska E, Pierzchała KB. MR-guided focused ultrasound: a new generation treatment of Parkinson’s disease, essential tremor and neuropathic pain. Interv Neuroradiol. 2014;20:275–82.CrossRefPubMedPubMedCentral
61.
Bauer R, Martin E, Haegele-Link S, Kaegi G, von Specht M, Werner B. Noninvasive functional neurosurgery using transcranial MR imaging-guided focused ultrasound. Parkinsonism Relat Disord. 2014;20 Suppl 1:S197–9.CrossRefPubMed
62.
Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2013;369:640–8.CrossRefPubMed
63.
Magara A, B€uhler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease. J Ther Ultrasound. 2014;2:11.CrossRefPubMedPubMedCentral
Metadata
Title
Surgical Treatment of Parkinson’s Disease
Authors
Leo Verhagen Metman, MD, PhD
Gian Pal, MD
Konstantin Slavin, MD
Publication date
01-11-2016
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 11/2016
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-016-0432-3